Struma ovarii with unique histological features: a case report.

Int J Clin Exp Pathol

Department of Molecular Diagnostic Pathology, School of Medicine, Iwate Medical University 19-1, Morioka 020-8505, Iwate, Japan.

Published: November 2017

AI Article Synopsis

  • A 57-year-old woman was diagnosed with a 13-cm multilocular cystic ovarian tumor identified as struma ovarii, showing distinct histological variations.
  • Histological analysis revealed both differentiated (follicular patterns) and de-differentiated (trabecular and small solid nests) patterns, with immunohistochemical studies indicating a change in E-cadherin expression between these components.
  • The study suggested that the transition from differentiated to de-differentiated tissue is linked to the loss of E-cadherin, possibly driven by increased ZEB1 expression, while noting no significant mutations in the tumor components.

Article Abstract

We present a case of struma ovarii with unique histological features. A 57-year-old woman presented with a 13-cm multilocular cystic ovarian tumor. Histological examination demonstrated both differentiated (follicular patterns) and de-differentiated (diffuse, trabecular and small-sized solid nests) patterns, suggesting a histological diagnosis of struma ovarii. To identify the pathogenesis of the tumor, immunohistochemical (TTF1, thyroglobulin, T3, E-cadherin, ZEB1, Slug, and Twist) and genetic ( and ) analyses were performed. TTF1, thyroglobulin, and T3 were detected in both tumor components. Additionally, although E-cadherin was detected in the differentiated component, loss of E-cadherin was obvious in the de-differentiated component. Finally, we examined ZEB1, Slug, and Twist expression to identify the role of epithelial-mesenchymal transition (EMT) in tumor pathogenesis. Slug, ZEB1, and Twist were not expressed in the differentiated component, but ZEB1 expression was observed in the de-differentiated component. Moreover, no or mutations were detected in either component. These findings suggested that the histological transition from the differentiated to de-differentiated tissue was closely associated with the loss of E-cadherin expression. This loss may have been related to increased ZEB1 expression and lack of neoplastic features due to the absence of and mutations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965871PMC

Publication Analysis

Top Keywords

struma ovarii
12
ovarii unique
8
unique histological
8
histological features
8
ttf1 thyroglobulin
8
zeb1 slug
8
slug twist
8
differentiated component
8
loss e-cadherin
8
de-differentiated component
8

Similar Publications

: Struma ovarii (SO) is an ovarian teratoma with the presence of ectopic thyroid tissue. Differentiated thyroid cancer (DTC) in SO is a rare finding. Management of DTC in SO is currently not clearly established.

View Article and Find Full Text PDF

Objectives: To improve preoperative diagnostic accuracy of struma ovarii by retrospectively reviewing magnetic resonance (MR) findings. It is beneficial to choose the most appropriate surgical modality for the patient.

Methods: We retrospectively reviewed the clinical course and MR characteristics of 52 patients who were diagnosed postoperatively with struma ovarii, pathologically, from two institutions.

View Article and Find Full Text PDF

Diagnostic Value of Nuclear Hybrid Imaging in Malignant Struma Ovarii: A Systematic Review of Case Reports.

Diagnostics (Basel)

November 2024

Faculty of Medicine, Department of Medical Imaging and Nuclear Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, 8 V. Babeș St., 400006 Cluj-Napoca, Romania.

Background: Struma ovarii is a rare tumor, a type of ovarian mature teratoma consisting over 50% of its mass in thyroid ectopic tissue; 5% to 10% of cases, as described in the literature, are malignant and well known as malignant struma ovarii or thyroid cancer from struma ovarii. Due to the limited number of malignant struma ovarii cases, the diagnostic and therapeutic approach of malignant struma ovarii lacks in standardization.

Methods: We performed a comprehensive search on the English language PubMed and Google Scholar.

View Article and Find Full Text PDF

Presentation and Management of Highly Differentiated Follicular Carcinoma of Ovarian Origin With Gene Variants.

JCEM Case Rep

December 2024

Division of Endocrinology, Gerontology, and Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

Struma ovarii (SO) is a rare subtype of ovarian teratoma composed of more than 50% thyroid tissue. Extraovarian spread of SO, called peritoneal strumosis, was previously considered benign given the lack of histological malignant features. However, the 2020 World Health Organization Classification of Female Genital Tumors reclassified peritoneal strumosis as highly differentiated follicular carcinoma of ovarian origin (HDFCO), highlighting its low-grade malignant potential.

View Article and Find Full Text PDF

Disease management of malignant struma ovarii.

Hell J Nucl Med

December 2024

Department of Nuclear Medicine, Qiantang Branch of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Article Synopsis
  • - Malignant struma ovarii (MSO) is a rare type of ovarian goiter that meets criteria for malignant thyroid tumors and can show invasive spread, with serum thyroglobulin (Tg) levels helping to differentiate it from other ovarian cancers.
  • - A case study is presented involving a 54-year-old woman with abdominal pain, diagnosed post-surgery with highly differentiated follicular thyroid carcinoma originating from both ovaries, which had spread to other areas.
  • - After undergoing total thyroidectomy and iodine-131 treatment, her follow-up after one year showed no significant abnormalities, highlighting the need for further discussion on clinical management and monitoring of Tg levels in MSO cases.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!